VKH Found in 5% of Uveitis Cases, More Common in Women
A meta-analysis published in the journal Eye found that Vogt-Koyanagi-Harada (VKH) disease occurs more frequently in Southeast Asia, East Asia, and Africa than in North America, Europe, and Oceania. Researchers analyzed 258 studies across 44 countries, concluding that racial and ethnic susceptibility likely influences the global distribution of this autoimmune disorder.
The study, conducted by a team of researchers from Chile, Argentina, Brazil, and Colombia, focused on individuals presenting with uveitis. Across six continents, the estimated frequency of VKH among these cases was 5.11% overall.
Why does VKH disease vary by region?
The researchers attribute these geographical differences to racial and ethnic susceptibility. According to the paper, VKH is historically associated with ethnic groups that have higher melanin counts.
The authors stated that the distribution aligns with regional demographic trends. They noted that the disease is more prevalent in populations from Asia and the Middle East and less common in countries with predominantly European-descended populations.
The study suggests this may reflect pathogenic mechanisms, including an autoimmune response against melanocytes and specific HLA-DR/DQ associations.
How do age and gender affect VKH frequency?
The data shows a predominance of female patients. Researchers noted that sex hormones influencing immune response or specific HLA-DR gene alleles restricted to females could explain this gender difference.
Age also plays a role. The overall relative frequency of VKH among uveitis cases was higher in adults than in pediatric studies.
The authors noted that while VKH can affect all ages, it is less prevalent in children, suggesting a greater disease burden in the adult population.
What are the regional disparities in South America and Africa?
South America showed a relatively low frequency compared to Africa and Asian subregions. The weighted frequency for the continent was 3.77%, with 7.42% in adults and 3.42% in children.
Within South America, Colombia reported the lowest weighted frequency in the region. In contrast, a study from Chile ranked ninth in overall VKH frequency among the analyzed studies.
Similar intra-regional variations appeared in Africa. According to the researchers, North Africa—a region with substantial Coptic, Berber, and Arab populations—showed higher prevalence than East African countries.
In Canada, the study found that First Nations populations exhibited outcomes significantly different from the general population, which the authors suggest may be influenced by racial composition.
What happens next for VKH research?
The researchers identified several shortcomings in current data, including geographical bias favoring the Global North and potential publication bias where small studies with high frequencies are underrepresented.
Future epidemiological research may focus more heavily on underrepresented regions. Such efforts could help the medical community better understand the global disease burden.
Improved data collection may lead to more efficient healthcare resource allocation in the future.
Frequently Asked Questions
What is Vogt-Koyanagi-Harada (VKH) disease?
It is a granulomatous autoimmune disorder historically associated with ethnic groups with higher melanin counts.
Which regions have the lowest rates of VKH?
According to the study, lower rates were found in North America, Europe, and Oceania.
Who is most likely to be affected by VKH?
The research found a predominance of female patients and a higher frequency in adults compared to the pediatric population.
How do you think targeted medical research could change healthcare access in underrepresented regions?